Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Control Release. 2011 Oct 30;155(2):312-6. doi: 10.1016/j.jconrel.2011.05.011. Epub 2011 May 18.

Polymer delivery systems for site-specific genome editing.

Author information

  • 1Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.

Abstract

Triplex-forming peptide nucleic acids (PNAs) can be used to coordinate the recombination of short 50-60bp "donor DNA" fragments into genomic DNA, resulting in site-specific correction of genetic mutations or the introduction of advantageous genetic modifications. Site-specific gene editing in hematopoietic stem and progenitor cells (HSPCs) could result in the treatment or cure of inherited disorders of the blood such as β-thalassemia or sickle cell anemia. Gene editing in HSPCs and differentiated T cells could also help combat HIV infection by modifying the HIV co-receptor CCR5, which is necessary for R5-tropic HIV entry. However, translation of genome modification technologies to clinical practice is limited by challenges in intracellular delivery, especially in difficult-to-transfect hematolymphoid cells. Here, we review the use of engineered biodegradable polymer nanoparticles for site-specific genome editing in human hematopoietic cells, which represent a promising approach for ex vivo and in vivo gene therapy.

Copyright © 2011 Elsevier B.V. All rights reserved.

PMID:
21620910
[PubMed - indexed for MEDLINE]
PMCID:
PMC3176956
Free PMC Article

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk